305 related articles for article (PubMed ID: 32005442)
1. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Shinjyo N; Parkinson J; Bell J; Katsuno T; Bligh A
J Integr Med; 2020 Mar; 18(2):125-151. PubMed ID: 32005442
[TBL] [Abstract][Full Text] [Related]
2. Berberine mitigates cognitive decline in an Alzheimer's Disease Mouse Model by targeting both tau hyperphosphorylation and autophagic clearance.
Chen Y; Chen Y; Liang Y; Chen H; Ji X; Huang M
Biomed Pharmacother; 2020 Jan; 121():109670. PubMed ID: 31810131
[TBL] [Abstract][Full Text] [Related]
3. The Role of Berberine in the Multi-Target Treatment of Senile Dementia.
Huang M; Chen S; Liang Y; Guo Y
Curr Top Med Chem; 2016; 16(8):867-73. PubMed ID: 26311424
[TBL] [Abstract][Full Text] [Related]
4. Vascular risk factors, cognitive decline, and dementia.
Duron E; Hanon O
Vasc Health Risk Manag; 2008; 4(2):363-81. PubMed ID: 18561512
[TBL] [Abstract][Full Text] [Related]
5. Berberine suppresses the ectopic expression of miR-133a in endothelial cells to improve vascular dementia in diabetic rats.
Yin S; Bai W; Li P; Jian X; Shan T; Tang Z; Jing X; Ping S; Li Q; Miao Z; Wang S; Ou W; Fei J; Guo T
Clin Exp Hypertens; 2019; 41(8):708-716. PubMed ID: 30472896
[No Abstract] [Full Text] [Related]
6. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
[TBL] [Abstract][Full Text] [Related]
7. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
[TBL] [Abstract][Full Text] [Related]
9. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
[TBL] [Abstract][Full Text] [Related]
10. Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease.
Jash K; Gondaliya P; Kirave P; Kulkarni B; Sunkaria A; Kalia K
Drug Dev Res; 2020 Apr; 81(2):144-164. PubMed ID: 31820484
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: Is Aβ a Crucial Factor in Both Pathologies?
Campos-Peña V; Toral-Rios D; Becerril-Pérez F; Sánchez-Torres C; Delgado-Namorado Y; Torres-Ossorio E; Franco-Bocanegra D; Carvajal K
Antioxid Redox Signal; 2017 Apr; 26(10):542-560. PubMed ID: 27368351
[TBL] [Abstract][Full Text] [Related]
12. Vascular cognitive impairment in diabetes mellitus: are prevention and treatment effective?
Zavoreo I; Madžar Z; Demarin V; Kes VB
Acta Clin Croat; 2014 Sep; 53(3):326-33. PubMed ID: 25509243
[TBL] [Abstract][Full Text] [Related]
13. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
[TBL] [Abstract][Full Text] [Related]
14. Berberine and barberry (Berberis vulgaris): A clinical review.
Imenshahidi M; Hosseinzadeh H
Phytother Res; 2019 Mar; 33(3):504-523. PubMed ID: 30637820
[TBL] [Abstract][Full Text] [Related]
15. Berberine: Pathways to protect neurons.
Lin X; Zhang N
Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
[TBL] [Abstract][Full Text] [Related]
16. Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells - In vitro models simulating Alzheimer's disease pathology.
Wong LR; Tan EA; Lim MEJ; Shen W; Lian XL; Wang Y; Chen L; Ho PC
Life Sci; 2021 Oct; 282():119824. PubMed ID: 34265361
[TBL] [Abstract][Full Text] [Related]
17. [Antidementia drugs].
Müller-Spahn F; Sollberger D; Wollmer MA
Ther Umsch; 2009 Jun; 66(6):432-40. PubMed ID: 19496039
[TBL] [Abstract][Full Text] [Related]
18. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.
Craft S
Arch Neurol; 2009 Mar; 66(3):300-5. PubMed ID: 19273747
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome, mild cognitive impairment, and dementia.
Panza F; Frisardi V; Seripa D; Imbimbo BP; Sancarlo D; D'Onofrio G; Addante F; Paris F; Pilotto A; Solfrizzi V
Curr Alzheimer Res; 2011 Aug; 8(5):492-509. PubMed ID: 21605050
[TBL] [Abstract][Full Text] [Related]
20. HRT and dementia.
Skoog I; Gustafson D
J Epidemiol Biostat; 1999; 4(3):227-51; discussion 252. PubMed ID: 10695961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
